Participate in Research

New Drug Trial for People with High Blood Pressure
Protocol: STUDY00007403
Full Title
A randomized, double-blind, placebo-controlled, parallel arm, multicenter, phase 2 study to evaluate the efficacy and safety of lorundrostat in subjects with uncontrolled hypertension on a standardized medication regimen
The University at Buffalo (UB) Department of Medicine is recruiting adults with hypertension (high blood pressure) for a clinical trial. The goal of the study is to test the safety and effectiveness of a new medication (Lorundrostat) for people with high blood pressure that is not well controlled.

Participants be enrolled in the study for about 3 months and will complete several study visits. They will be randomly assigned (which happens by chance, like flipping a coin) to one of two groups: (1) will take the study medicine and 2-3 high blood pressure medications or (2) will take a placebo (which looks like the study pill but contains no active medicine) and 2-3 high blood pressure medications. They will also complete physical exams and lab tests. Participants will be paid $50 for each study visit.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Adults 18 years or older Have been diagnosed with hypertension (high blood pressure) that is not well controlled
Age Group: Adults
Principal Investigator: JOSEPH IZZO Open Study
+1 716-898-5653
+1 716-898-5234
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions